Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same
申请人:Les Laboratoires Servier
公开号:US07202255B2
公开(公告)日:2007-04-10
Compounds of formula (I):
wherein:
A is as defined in the description,
Y represents a group selected from an oxygen atom and a methylene group,
R2 represents a hydrogen atom and in that case:
R3 represents a group selected from a hydrogen atom and the groups linear or branched (C1–C6)alkyl, aryl, aryl-(C1–C6)alkyl (in which the alkyl moiety is linear or branched) and SO2CF3,
or R2 and R3 form a bond,
R1 represents a group selected from a hydrogen atom and the groups linear or branched (C1–C6)alkyl, aryl and aryl-(C1–C6)alkyl (in which the alkyl moiety is linear or branched) or a linear or branched (C1–C6)alkylene chain,
Z1 and Z2 each represent a hydrogen atom or
Z1 and Z2, together with the carbon atoms carrying them, form a phenyl group.
Medicaments.
化学式为(I)的化合物,其中:A在描述中定义,Y表示从氧原子和亚甲基基团中选择的一个基团,R2表示氢原子,此时:R3表示从氢原子和线性或支链(C1-C6)烷基,芳基,芳基-(C1-C6)烷基(其中烷基基团是线性或支链的)和SO2CF3中选择的一个基团,或者R2和R3形成键,R1表示从氢原子和线性或支链(C1-C6)烷基,芳基和芳基-(C1-C6)烷基(其中烷基基团是线性或支链的)或线性或支链(C1-C6)烷基链中选择的一个基团,Z1和Z2分别表示氢原子或Z1和Z2与携带它们的碳原子一起形成苯基。药物。